Testing faster diagnosis of serious lung fungal infection
Part of Infections, Lungs & breathing clinical trials.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breathing problems such as fast breathing (respiratory rate 30 or higher)
- Your oxygen levels are low (PaO2/FiO2 ratio 250 or lower)
- Your chest scans show infection in more than one lung area (multilobar infiltrates)
- You are very unwell, such as confusion, fever (over 38°C), or low body temperature (under 36°C)
- Blood tests show signs of severe illness, like abnormal white blood cells, low platelets, kidney stress, or shock requiring strong fluids/medicines
- A lung sample test is done (bronchoalveolar lavage fluid and/or suctioned material from the breathing tube)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether repeated PCR tests for a fungus called Aspergillus fumigatus (in blood or lung fluid) can help doctors track how well treatment is working for a serious lung infection called invasive aspergillosis. It is for people who already had a positive PCR test at diagnosis.
This trial tests if a simple breath analysis can detect invasive fungal infections early in people with acute leukemia who are undergoing chemotherapy and have a low white blood cell count. Early detection could help start treatment sooner.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study is developing a tool to better predict fungal pneumonia in people who come to the emergency department or hospital with pneumonia. By analyzing samples from your lungs and other data, researchers hope to improve diagnosis and treatment decisions.
This study will use special scans to see how an inhaled antifungal medicine (amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis. The results may help doctors choose better treatments in the future.
This trial tests a stronger antifungal medicine (liposomal amphotericin B) for people with a serious fungal lung infection who also have liver problems. It aims to see if this treatment is safe and effective for ICU patients.
Hear when a new Respiratory Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.